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interview, there have been assumptions that destitute popula-
tions and minority populations do not need genomic testing 
because infectious illnesses are a more prevalent and pressing 
concern than genetic diseases in such populations. However, 
over the years it has been proven that genetic diseases, such as 
heart disease and other chronic diseases, are also a significant 
concern in poor populations and minority populations just as 
in affluent or majority populations (Mullin 2016). 
Moreover, the genomes of many minorities and indigenous 
populations are more difficult to decode because of the nu-
merous diverse communities within each minority and indig-
enous population. This complexity appears to deter research-
ers because of the assumptions that the complexity will not 
provide accurate data to produce treatments (Santos 2008). 
For those few who do take on the challenge, the difficulty 
comes with great reward in discovering mutations and vari-
ants that often prove useful for medicine (Santos 2008). The 
unique qualities of minority and indigenous genomes provide 
greater knowledge on how genetics influence drug interac-
tions during treatment and other health issues like diabetes 
(Popejoy 2016). Therefore, concerning medical care, minority 
patients require just as much genetic data as the European 
patients, if not more because of the great diversity within the 
genomes of minority and indigenous populations that can 
provide great benefit to treatment and drug development. 
While ethics and assumptions show how the research com-
munity has been wrong in its execution of genetic studies, 
some aspects of the logistics of GWAS can hinder the abili-
ty to achieve diversity in studies. The primary logistical issue 
connects to historical points already mentioned. If people 
do not wish to contribute their genetic information due to 
historical oppression, discrimination, and unethical practice 
under false assumptions, then it proves extremely difficult to 
gather data on such populations today. The inability to attain 
samples from minorities slows progress towards diversifying 
the GWAS Catalog and other genetic databases, despite ef-
forts by programs like All Of Us, which was created by the 
NIH in 2018 to develop a database of at least a million diverse 
patient genomes (Yeager 2019). 
Due to how long the databases have been filled with Europe-
an majority, another logistical issue stems from the analyti-
cal models used to process the data produced by these mas-
sive GWAS. Analytical methods called ancestry metrics are 
used to process genomic data found in GWAS databases, but 
these metrics do not properly analyze an individual of a di-
verse background (Bustamante 2011). As a result, our current 
methodology of analysis likely produces a significant amount 
of error for genomes that carry more variants and deviate 
from the more homogenous populations that the metrics are 
based upon (Bustamante 2011). 
 The history of genetics research is riddled with ethical 
and logistical issues that have contributed to the present lack 
of diversity in GWAS. Incidents such as sampling bias based 
on supposed “race” and violation of minority patients’ con-
sent rights have caused logical issues for present day GWAS 
that seek to gather diverse genomes but cannot due to a lack 
of trust in research. Thankfully, several programs, similar to 
All Of Us, have been commissioned in recent years to create a 
better relationship between the public and researchers. While 
the past cannot be changed, the way in which future GWAS 
are constructed and conducted can be adjusted to achieve a 
genetic database that properly represents and provides Preci-
sion Medicine for the entire human species. 
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Precision medicine is a movement that seeks to serve a pa-
tient’s individual medical needs with a tailored level of treat-
ment. Such a practice requires an essential framework of 
genetic information to allow doctors to make accurate treat-
ment decisions. Genome-wide association studies (GWAS) 
provide massive amounts of information for databases, such 
as the GWAS Catalog; however, there is an apparent lack of 
diversity in the genomics data available to researchers and 
drug-developers. The majority of participants in GWAS are 
of European descent. As of January 2019, 78 percent of ge-
netics contributed by GWAS have been of European descent; 
while, only 22 percent are minorities (Yeager 2019). Stem-
ming from a history of discrimination and unfair logistics, 
the lack of diversity in genomic databases undercuts the ac-
cessibility and function of Precision Medicine, and this issue 
needs to be resolved.
After the completion of the human genome project in 2003, 
the ability to conduct GWAS and create a database of genetic 
information became possible and affordable. Over the past 
two decades, the data on human genetics has grown. Based 
on this growth, one would assume our knowledge of treat-
ments based on the unique genetic makeup patients would 
be vast and precise by now. At times, however, the procla-
mations of Precision Medicine overlook the history of ge-
netics— the percentage of European genetics in the GWAS 
Catalog remains the majority, even if they are not the ma-
jority by global population (Popejoy 2016). To understand 
how the lack of diversity in genetic databases developed, 
one must look at the questionable ethical history, medical 
assumptions, and objective logistics of genetic studies. 
Genetic research has had its share of ethically turbulent mo-
ments. As discussed by journalist Chou, the conversation be-
tween the scientific community and the public often struggles 
to distinguish between race and ethnicity of participants in 
genome studies (Chou 2017). The social construction of race 
is false, based on external phenotypes like skin color, and not 
backed by science because significant genetic variation ex-
ists even within the historical “five races”—African, Asian, 
European, Native American, and Oceanian— that have been 
used as a standard of categorization (Chou 2017). The genetic 
isolation of populations within the human species results in 
countless variations in phenotype and contributes to general 
ethnic differences and tendencies, which can greatly impact a 
patient’s health and lifestyle from a medical perspective. Thus, 
using ethnicity to minimize variables when categorizing data 
experimentally can be useful, but the variation within ethnic-
ity remains and makes constructing GWAS difficult (Chou 
2017). 
Another ethical factor, besides the issue of distinguishing 
race from ethnicity when gathering patient samples, is the 
blatant harm genetics research has inflicted on uninformed 
populations. One of the most striking examples concerns the 
Havasupai tribe in Arizona (Santos 2008). The Havasupai 
tribe agreed to a genetic study proposed by Arizona State 
University in the 1990s and were under the impression that 
the researchers would report the results and provide insight 
into the high frequency of type-2 diabetes in the tribe (Santos 
2008). However, the Havasupai never received a report from 
the study; in fact, the cell lines produced from the tribe’s sam-
ples were distributed among other universities, where studies 
deviating from the original agreement were conducted with-
out the Havasupai’s consent (Santos 2008). Consequently, the 
Havasupai filed lawsuits on the grounds of “exploitation and 
violation of civil rights” (Santos 2008). Numerous incidents 
similar to this have historically occurred in minority popu-
lations; a well-known example being the exploitation of cells 
from Henrietta Lacks, also known as HeLa cells. With such 
an unethical history of interaction with research endeavors, 
minorities commonly refuse to participate in genetic research 
studies, which contributes to the lack of diversity in GWAS 
(Santos 2008). 
Along with ethical issues, genetics research has also been 
conducted with certain assumptions in mind that simply do 
not hold true. As Adebowale Adeyemo, deputy director of the 
Center for Research on Genomics and Global Health at the 
National Human Genome Research Institute, highlights in an 
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